Supplements

Recent Advances In The Treatment of Multiple Myeloma: Proceedings From a Post-EHA Roundtable

Paul Richardson, MD, Kenneth C. Anderson, MD, Jesús San Miguel, MD, Evangelos Terpos, MD, PhD

Valid: October 18th, 2011 - October 18th, 2012

Considerations in Lymphoma Ask the Experts: Diffuse Large B-Cell Lymphoma

Julie M. Vose, MD, MBA, Colleen Ross, RN, MSN, MHA, OCN, Susanne Liewer, PharmD, BCOP

Valid: October 18th, 2011 - October 18th, 2012

Recent Advances In The Treatment Of Multiple Myeloma: Proceedings From a Post-ASCO Roundtable

Paul Richardson, MD, Kenneth C. Anderson, MD, Jesús San Miguel, MD, Evangelos Terpos, MD, PhD

Valid: September 6th, 2011 - September 6th, 2012

Cases in Multiple Myeloma: The Role of Oncology Pharmacists on an Interprofessional Team to Improve Patient Care and Outcomes

Stephanie S. Minich, PharmD, BCOP

Valid: August 29th, 2011 - August 29th, 2012

Cost Implications for Novel Therapies and Strategies in the Treatment of NSCLC: Perspectives and Clinical Updates from ASCO 2011

Ira M. Klein, MD, MBA, FACP

Valid: August 19th, 2011 - August 19th, 2012

Considerations in Multiple Myeloma Ask the Experts: Retreatment

Jeffrey Wolf, MD, Jennifer Knoche, RN, BSN, Helen T. Wu, PharmD, BCOP

Valid: August 12th, 2011 - August 12th, 2012

Optimizing New and Emerging Therapies for Treatment and Symptom Management of Multiple Sclerosis in Managed Care

Gary M. Owens, MD, Bruce L. Hughes, MD , Sonya J. Lewis, RPh, MBA

Valid: August 2nd, 2011 - August 2nd, 2012

Considerations in Lymphoma Ask the Experts: Mantle Cell Lymphoma

Michael E. Williams, MD, Kimberly F. Leake, RN, MSN, FPN-C, Kathlene A. DeGregory, PharmD, BCOP

Valid: August 1st, 2011 - August 1st, 2012

Recent Advances In The Treatment Of Multiple Myeloma: Proceedings From a Post-IMW Roundtable

Paul Richardson, MD, Kenneth C. Anderson, MD, Sergio Giralt, MD, Jesús San Miguel, MD, Evangelos Terpos, MD, PhD

Valid: August 1st, 2011 - August 1st, 2012

The Evolving Role of Outcomes and End Points in Evaluating Therapy for Hematologic Malignancies: Value-Driven Benefit Design and Utilization Management Strategies

Gary C. Yee, PharmD, FCCP, BCOP, James T. Kenney Jr, RPh, MBA, Michael Mauro, MD

Valid: July 15th, 2011 - July 15th, 2012

1
2
3
4
5
6

Page 3 of 13
Results 21 - 30 of 122